McKesson (MCK) Renews Pharmaceutical Distribution Agreement with CVS Caremark (CVS)
More News related to CVS
- Top 10 News Items 11/02-11/06: Unemployment Rate Now Over 10%, Fed to Keep Rates 'Exceptionally Low' for 'Extended Period', Buffett Does the Biggest Deal of His Life
- William Blair Downgrades CVS Caremark (CVS) to Market Perform
- CVS (CVS) Bounces A Little After Yesterday's 20% Haircut
- Highlights From CVS's Q3 Conference Call: Guides Slightly Higher for FY - Still In-line with Estimates
- CVS Caremark (CVS) volume and volatility elevated; shares sell off on PBM customer losses
More News related to MCK
- Manson Creek Resources Negotiates Acquisition of Virgin Arm Gold Project
- Manson Creek Secures Ownership of Meridian Gold Project
- McKesson Board Turns Blind Eye to Shareholders
- McKesson Declares Quarterly Dividend October 30, 2009
- Auriga Reiterates a 'Buy' Rating on McKesson Corp (MCK); Raises Estimates & PT
More News related to Corporate News
- Trex Company (TWP) Announces Refinancing of Revolving Credit Facility
- Infineon Technologies (IFNNY) Completes Sale of Wireline Business to Lantiq
- Highlights From NVDA's Q3 Conference Call: Steady Increase in Demand Driven By Healthy Marketing Environment and New Apps
- Ocean Power Technologies (OPTT) Higher After Award For Australian Power Project
- Highlights From SBUX's Q4 Conference Call: Sees FY10 EPS Growth Up 15-20%, Continued Expansion in China,
McKesson Corporation (NYSE: MCK) announced that it has renewed its current distribution agreement to supply CVS Caremark (NYSE: CVS) with branded and generic drugs.
"CVS Caremark's decision to renew its agreement with McKesson is reflective of the trusted relationship between our two companies and the value McKesson has delivered to CVS Caremark over the years," said Paul Julian, executive vice president, group president, McKesson Corporation. "McKesson's comprehensive supply chain solutions help CVS Caremark ensure the highest levels of product availability and product integrity, empowering CVS Caremark to provide outstanding pharmaceutical care and further strengthen its competitive position."
Related Categories
Corporate NewsStocks Mentioned
+0.92Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
